Dopamine agonist used in diabetes
Bromocriptine and cabergoline are dopamine agonists but bromocriptine usage in type 2 diabetes is approved.It has an interesting mechanism of action by inhibiting the dopamine dip that causes in early morning leading to hyperglycemia. Ref: Goodman and Gillman 13th ed
Metformin
Bromocriptine
Cabergoline
Vanadium salts
Endocrinology